FTO and nonpapillary renal cell carcinoma: FTO, as m6A “erasers”, has also been reported to have pro‐tumorigenic function in acute myeloid leukaemia and glioblastoma,34, 37 but we show that FTO plays a critical anti‐tumorigenic role in ccRCC.